Export

EN
FR
Hydroxocobalamin
Essential medicine status
Section:
10. Medicines affecting the blood 10.1. Antianaemia medicines
ATC codes: B03BA03
EMLc
Indication
Megaloblastic anaemia due to vitamin B12 deficiency ICD11 code: 3A01.Z
INN
Hydroxocobalamin
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Parenteral > General injections > IM: 1 mg per mL in 1 mL ampoule (as acetate) ; 1 mg per mL in 1 mL ampoule (as hydrochloride) ; 1 mg per mL in 1 mL ampoule (as sulfate)
EML status history
First added in 1979 (TRS 641)
Changed in 1982 (TRS 685)
Changed in 1989 (TRS 796)
Changed in 2007 (TRS 950)
Changed in 2011 (TRS 965)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Hydroxocobalamin
DrugBank
Hydroxocobalamin
Summary of evidence and Expert Committee recommendations
Various salts of hydroxocobalamin (acetate, hydrochloride and sulfate) were specified in the listing.